The COVID-19 Pandemic – News and Features

We’ve known for more than a century that women outlive men. But new research shows that, at least in the United States, the gap has been widening for more than a decade.

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. The findings improve understanding of the dynamics of such antibodies and are an important building block for further research.

An international team of researchers has developed a handheld, non-invasive device that can detect biomarkers for Alzheimer’s and Parkinson’s Diseases.

Andrew Schulman explores why we need allogeneic therapies, the importance of collaboration to keep the momentum, and challenges and predictions for the future.

A new antifungal molecule, devised by tweaking the structure of prominent antifungal drug Amphotericin B, has the potential to harness the drug’s power against fungal infections while doing away with its toxicity.

Scientists have found that specially processed samples of willow bark extract have an antiviral effect which isn’t seen in already known medical compounds from willow bark, such as salicylic acid, the precursor to modern aspirin.

Studying the evolutionary history of influenza viruses to quantitatively analyze how they evolved may help predict future strains and guide vaccine development.

Brain health in over 50s deteriorated more rapidly during the pandemic, even if they didn’t have COVID-19, reports a new study that links the pandemic to sustained cognitive decline.

A virus diagnosis device that gives lab-quality results within just three minutes has been invented by engineers at the University of Bath, who describe it as the ‘world’s fastest Covid test’.

Most cancers become deadly by keeping a low profile, causing no symptoms until they’re too advanced to treat. Researchers have developed a highly sensitive blood test that can detect a key protein produced by cancer cells.